The addition of molecular profiling of DT with inclusion of CTNNB1 gene mutation status improves the accuracy of the predictive models of recurrence as demonstrated by our group in a recent study (data not published) and other authors.16 Moreover, the better understanding of molecular factors related to disease behavior could predict tumor progression and better guide the therapeutic approach. This evidence concerns the gene CTNNB1 and neoplasm.